Table 4.
Groups | Young’s Modulus at Initial (MPa) | Young’s Modulus after 14 Days (MPa) | Young’s Modulus after 28 Days (MPa) | p-Value |
---|---|---|---|---|
(MEAN ± SD) | (MEAN ± SD) | (MEAN ± SD) | ||
PCL | 28.01 ± 5.98 | 27.07 ± 2.13 | 26.07 ± 2.08 | 1.89 |
PCL + BG2% | 55.46 ± 8.06 | 54.22 ± 8.61 | 53.18 ± 14.25 * | 0.04 |
PCL + BG5% | 53.28 ± 6.76 | 53.10 ± 0.92 | 52.81 ± 8.43 | 1.7 |
PCL + BG10% | 51.34 ± 8.69 | 51.29 ± 0.87 | 50.87 ± 15.46 | 1.45 |
PCL + BG15% | 31.74 ± 1.48 | 31.26 ± 1.20 | 31.05 ± 10.03 | 1.34 |
PCL + HA2% | 57.16 ± 7.39 | 56.29 ± 7.84 | 55.72 ± 11.16 * | 0.04 |
PCL + HA5% | 37.70 ± 2.53 | 37.54 ± 0.88 | 36.94 ± 12.36 | 1.45 |
PCL + HA10% | 31.13 ± 2.03 | 31.07 ± 0.99 | 30.96 ± 1.98 | 1.84 |
PCL + HA15% | 31.07 ± 3.39 | 31.06 ± 1.40 | 30.30 ± 17.64 | 1.56 |
*, p < 0.05 considered statistically significant compared between the groups.